5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 3.73▼ | 3.69▲ | 3.68▲ | 3.75▼ | 3.55▲ |
MA10 | 3.71▲ | 3.69▲ | 3.73▼ | 3.81▼ | 4.36▼ |
MA20 | 3.69▲ | 3.75▼ | 3.79▼ | 3.59▲ | 4.52▼ |
MA50 | 3.72▲ | 3.82▼ | 3.80▼ | 4.54▼ | 3.98▼ |
MA100 | 3.79▼ | 3.82▼ | 3.69▲ | 4.44▼ | 5.75▼ |
MA200 | 3.79▼ | 3.65▲ | 3.76▼ | 3.35▲ | 43.73▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.007▲ | -0.004▼ | -0.016▼ | 0.079▲ | -0.201▼ |
RSI | 54.039▲ | 45.293▼ | 45.406▼ | 45.261▼ | 46.354▼ |
STOCH | 83.813▲ | 23.447 | 11.291▼ | 50.777 | 8.352▼ |
WILL %R | -41.667 | -70.370 | -78.947▼ | -40.909 | -88.043▼ |
CCI | 98.450 | 4.936 | -45.323 | 13.082 | -71.590 |
MA | $KOD Price Crossed Below MA(13) | Set Alert |
Wednesday, May 15, 2024 10:39 PM
Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics ...
|
Wednesday, May 15, 2024 08:06 PM
KOD stock results show that Kodiak Sciences beat analyst estimates for earnings per share the first quarter of 2024.More From InvestorPlace The #1 AI Investment Might Be This Company You’ve Never ...
|
Wednesday, May 15, 2024 01:02 PM
Kodiak Sciences Inc. (Nasdaq: KOD), today reported business highlights and financial results for the quarter ended March 31, 2024.
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
16/05/24 | 3.775 | 3.91 | 3.64 | 3.72 | 263,495 |
15/05/24 | 3.94 | 4.03 | 3.72 | 3.74 | 347,866 |
14/05/24 | 3.92 | 4.06 | 3.77 | 3.84 | 284,036 |
13/05/24 | 3.71 | 3.88 | 3.71 | 3.84 | 215,150 |
10/05/24 | 3.86 | 3.91 | 3.59 | 3.61 | 252,320 |
09/05/24 | 3.85 | 3.965 | 3.76 | 3.80 | 415,341 |
08/05/24 | 3.91 | 3.97 | 3.75 | 3.83 | 269,914 |
07/05/24 | 3.94 | 4.08 | 3.8416 | 3.98 | 425,460 |
06/05/24 | 3.82 | 4.055 | 3.75 | 3.94 | 557,995 |
03/05/24 | 3.85 | 4.06 | 3.73 | 3.77 | 305,557 |
|
|
||||
|
|
||||
|
|